THEM6

gene
On this page

Also known as DSCD75

Summary

THEM6 (thioesterase superfamily member 6, HGNC:29656) is a protein-coding gene on chromosome 8q24.3, encoding Protein THEM6 (Q8WUY1).

Predicted to be located in extracellular region.

Source: NCBI Gene 51337 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 34 total
  • Druggable target: yes
  • MANE Select transcript: NM_016647

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:29656
Approved symbolTHEM6
Namethioesterase superfamily member 6
Location8q24.3
Locus typegene with protein product
StatusApproved
AliasesDSCD75
Ensembl geneENSG00000130193
Ensembl biotypeprotein_coding
Entrez51337

Gene structure

Transcript identifiers

Ensembl transcripts: 6 — 4 protein_coding, 1 retained_intron, 1 nonsense_mediated_decay

ENST00000336138, ENST00000518798, ENST00000520217, ENST00000866704, ENST00000866705, ENST00000866706

RefSeq mRNA: 2 — MANE Select: NM_016647 NM_001363000, NM_016647

CCDS: CCDS6386

Canonical transcript exons

ENST00000336138 — 2 exons

ExonStartEnd
ENSE00001355879142735326142736927
ENSE00001355886142727223142727859

Expression profiles

Bgee: expression breadth ubiquitous, 188 present calls, max score 90.66.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 21.6223 / max 243.1974, expressed in 1738 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
9136415.42221670
913636.20011457

Top tissues by expression

271 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right lobe of liverUBERON:000111490.66gold quality
mucosa of transverse colonUBERON:000499190.40gold quality
apex of heartUBERON:000209887.37gold quality
lower esophagus mucosaUBERON:003583486.14gold quality
hindlimb stylopod muscleUBERON:000425285.95gold quality
right adrenal gland cortexUBERON:003582785.88gold quality
right frontal lobeUBERON:000281085.71gold quality
right adrenal glandUBERON:000123385.36gold quality
body of pancreasUBERON:000115085.32gold quality
left adrenal gland cortexUBERON:003582585.13gold quality
metanephros cortexUBERON:001053385.10gold quality
left adrenal glandUBERON:000123484.90gold quality
esophagus mucosaUBERON:000246984.48gold quality
prefrontal cortexUBERON:000045184.28gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099183.70gold quality
adrenal cortexUBERON:000123583.64gold quality
body of stomachUBERON:000116183.35gold quality
right uterine tubeUBERON:000130283.20gold quality
adult mammalian kidneyUBERON:000008283.13gold quality
heart left ventricleUBERON:000208483.04gold quality
anterior cingulate cortexUBERON:000983582.98gold quality
cingulate cortexUBERON:000302782.90gold quality
skin of legUBERON:000151182.80gold quality
minor salivary glandUBERON:000183082.56gold quality
Brodmann (1909) area 9UBERON:001354082.50gold quality
transverse colonUBERON:000115782.37gold quality
liverUBERON:000210782.33gold quality
cardiac ventricleUBERON:000208282.27gold quality
right lobe of thyroid glandUBERON:000111982.16gold quality
adrenal glandUBERON:000236982.09gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes10.13

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

41 targeting THEM6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4650-5P99.9864.69999
HSA-MIR-6778-3P99.9667.292693
HSA-MIR-674599.7465.331321
HSA-MIR-6715B-5P99.6469.631420
HSA-MIR-182799.6368.573265
HSA-MIR-426999.5569.891373
HSA-MIR-106A-3P99.5367.58995
HSA-MIR-314799.5266.34388
HSA-MIR-361299.4566.021333
HSA-MIR-65099.4565.771309
HSA-MIR-94099.3766.142064
HSA-MIR-431699.3765.751360
HSA-MIR-6808-5P99.3166.232150
HSA-MIR-6893-5P99.3166.252119
HSA-MIR-149-5P99.2567.161315
HSA-MIR-312599.1468.492269
HSA-MIR-3160-3P99.0764.78955
HSA-MIR-4695-5P99.0664.871151
HSA-MIR-1207-3P98.9966.221532
HSA-MIR-4755-3P98.7765.591915
HSA-MIR-6804-3P98.7264.82852
HSA-MIR-1301-3P98.6468.271071
HSA-MIR-504798.6468.621035
HSA-MIR-31-5P98.5868.351239
HSA-MIR-4632-5P97.8265.381470
HSA-MIR-466097.7967.441328
HSA-MIR-4640-5P97.4266.331543
HSA-MIR-4726-5P97.2465.671299
HSA-MIR-428697.2064.371587
HSA-MIR-3616-3P96.9665.45983

Literature-anchored findings (GeneRIF, showing 1)

  • THEM6 is a prognostic biomarker for breast cancer and is associated with immune infiltration. (PMID:38081884)

Cross-species orthologs

6 orthologs

OrganismSymbolGene ID
danio_reriothem6ENSDARG00000100260
danio_rerioTHEM6ENSDARG00000103914
mus_musculusThem6ENSMUSG00000056665
rattus_norvegicusThem6ENSRNOG00000005929
drosophila_melanogasterCG4666FBGN0029838
drosophila_melanogasterCG4660FBGN0029839

Protein

Protein identifiers

Protein THEM6Q8WUY1 (reviewed: Q8WUY1)

Alternative names: Mesenchymal stem cell protein DSCD75, Thioesterase superfamily member 6

All UniProt accessions (3): Q8WUY1, B4DWJ7, H0YAR9

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Secreted.

Similarity. Belongs to the THEM6 family.

RefSeq proteins (2): NP_001349929, NP_057731* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR029069HotDog_dom_sfHomologous_superfamily
IPR051490THEM6_lcsJ_thioesteraseFamily

Pfam: PF13279

UniProt features (5 total): signal peptide 1, chain 1, modified residue 1, sequence variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8WUY1-F194.920.96

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 199

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 61 (showing top): MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP, GRADE_COLON_AND_RECTAL_CANCER_UP, NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON, GEORGES_TARGETS_OF_MIR192_AND_MIR215, chr8q24, ERBB2_UP.V1_UP, MEK_UP.V1_UP, PTEN_DN.V2_DN, RPS14_DN.V1_DN, STK33_NOMO_DN, FEV_TARGET_GENES, FOXD2_TARGET_GENES, PCGF1_TARGET_GENES, PHF21A_TARGET_GENES, SKIL_TARGET_GENES

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (1): extracellular region (GO:0005576)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure1

Protein interactions and networks

STRING

388 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
THEM6FLYWCH2Q96CP2471
THEM6TMEM200AQ86VY9459
THEM6SYNGR4O95473454
THEM6PROSER2Q86WR7436
THEM6TMEM220Q6QAJ8430
THEM6JRKO75564425
THEM6SLC4A7Q9Y6M7403
THEM6LYNX1P0DP58389
THEM6ANKRD29Q8N6D5358
THEM6NCKAP5LQ9HCH0348
THEM6PLEKHG1Q9ULL1336
THEM6UBXN2BQ14CS0323
THEM6LETM1O95202320
THEM6SEPTIN5Q99719315
THEM6MID1IP1Q9NPA3314

IntAct

123 interactions, top by confidence:

ABTypeScore
IFT70BIFT56psi-mi:“MI:0914”(association)0.790
CFTRESYT2psi-mi:“MI:2364”(proximity)0.710
CFTRESYT2psi-mi:“MI:0914”(association)0.710
P2RX4FAM20Bpsi-mi:“MI:0914”(association)0.640
TEX28TMCC2psi-mi:“MI:0914”(association)0.640
TRDNTMEM223psi-mi:“MI:0914”(association)0.640
GDPD5GOLIM4psi-mi:“MI:0914”(association)0.530
XPO1psi-mi:“MI:0914”(association)0.530
SRPRBCTDNEP1psi-mi:“MI:0914”(association)0.530
TBC1D15UBXN8psi-mi:“MI:0914”(association)0.530
APLNRSLC33A1psi-mi:“MI:0914”(association)0.530
EVA1CSTK25psi-mi:“MI:0914”(association)0.530
SIDT2AP3D1psi-mi:“MI:0914”(association)0.530
TMEM63AAP3D1psi-mi:“MI:0914”(association)0.530
CHRNA4FZD6psi-mi:“MI:0914”(association)0.530
LDLRAD1ADAM10psi-mi:“MI:0914”(association)0.530
SLC30A2ESYT2psi-mi:“MI:0914”(association)0.530
SLC6A8ILVBLpsi-mi:“MI:0914”(association)0.530
UNC93B1GPR89Apsi-mi:“MI:0914”(association)0.530
ERBB2NDUFA4psi-mi:“MI:0914”(association)0.530
ESR1psi-mi:“MI:0914”(association)0.460
FLT4ILVBLpsi-mi:“MI:0914”(association)0.420
Them6psi-mi:“MI:0915”(physical association)0.400
CFTRSNHG32psi-mi:“MI:0914”(association)0.350
E5ESYT2psi-mi:“MI:0914”(association)0.350
HSCBRBP5psi-mi:“MI:0914”(association)0.350

BioGRID (180): THEM6 (Affinity Capture-MS), THEM6 (Affinity Capture-MS), THEM6 (Affinity Capture-MS), THEM6 (Affinity Capture-MS), THEM6 (Proximity Label-MS), THEM6 (Proximity Label-MS), THEM6 (Proximity Label-MS), THEM6 (Proximity Label-MS), THEM6 (Affinity Capture-MS), THEM6 (Affinity Capture-MS), THEM6 (Affinity Capture-MS), THEM6 (Affinity Capture-MS), THEM6 (Affinity Capture-MS), THEM6 (Affinity Capture-MS), THEM6 (Affinity Capture-MS)

ESM2 similar proteins: A1A4L8, A1A4Q9, A1L134, A2BDX3, A5YM72, A6H707, B0BLZ5, B0JZP3, G3MZR2, O43292, O60831, O89109, P70295, Q11130, Q2TBP5, Q2V8X7, Q32NY4, Q3UPE3, Q4R4E4, Q4R4I9, Q5XIE1, Q5ZIW1, Q66HR0, Q6IQX7, Q6NRK8, Q6P2H8, Q7L1V2, Q80ZW2, Q86VU5, Q8IZ52, Q8N3Y3, Q8NE01, Q8NF37, Q8NI29, Q8TAC2, Q8TCD5, Q8TD43, Q8WUY1, Q92839, Q96DE0

Diamond homologs: A6H707, B0BLZ5, B0JZP3, Q5XIE1, Q6NRK8, Q80ZW2, Q8WUY1, Q9W440

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 167 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Synthesis of PC518.4×9e-04
R-HSA-4253931011.7×3e-06
SLC-mediated transmembrane transport136.9×8e-06

GO biological processes:

GO termPartnersFoldFDR
phosphatidylcholine biosynthetic process528.1×4e-04
cell volume homeostasis521.0×9e-04
amino acid transport613.1×1e-03
transmembrane transport1113.0×8e-07

Disease & clinical

Clinical variants and AI predictions

ClinVar

34 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance34
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

459 predictions. Top by Δscore:

VariantEffectΔscore
8:142727858:GG:Gdonor_gain1.0000
8:142727859:GG:Gdonor_gain1.0000
8:142735314:T:TAacceptor_gain1.0000
8:142735323:CA:Cacceptor_loss1.0000
8:142735324:A:AGacceptor_gain1.0000
8:142735324:AGGT:Aacceptor_gain1.0000
8:142735324:AGGTG:Aacceptor_gain1.0000
8:142735325:G:GTacceptor_gain1.0000
8:142735325:GGT:Gacceptor_gain1.0000
8:142735325:GGTG:Gacceptor_gain1.0000
8:142735325:GGTGG:Gacceptor_gain1.0000
8:142727855:GCAGG:Gdonor_gain0.9900
8:142727856:CAGGG:Cdonor_loss0.9900
8:142727859:GGTGA:Gdonor_loss0.9900
8:142727860:G:Cdonor_loss0.9900
8:142727860:G:GGdonor_gain0.9900
8:142727861:T:Adonor_loss0.9900
8:142735321:T:TAacceptor_gain0.9900
8:142735324:AG:Aacceptor_gain0.9900
8:142735325:GG:Gacceptor_gain0.9900
8:142727862:GAGCG:Gdonor_loss0.9800
8:142734386:G:GTdonor_gain0.9800
8:142734324:GC:Gdonor_gain0.9000
8:142728654:A:Tdonor_gain0.8900
8:142734357:G:Tdonor_gain0.8800
8:142727860:G:Tdonor_gain0.8600
8:142727863:AGCGG:Adonor_loss0.8600
8:142727857:AGG:Adonor_gain0.8500
8:142727858:GGG:Gdonor_gain0.8500
8:142729102:C:Gdonor_gain0.8500

AlphaMissense

1303 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
8:142727756:T:CF137S0.988
8:142727543:A:TN66I0.984
8:142735383:A:CS191R0.979
8:142735385:C:AS191R0.979
8:142735385:C:GS191R0.979
8:142727695:T:CF117L0.977
8:142727697:C:AF117L0.977
8:142727697:C:GF117L0.977
8:142727755:T:CF137L0.977
8:142727757:T:AF137L0.977
8:142727757:T:GF137L0.977
8:142727544:C:AN66K0.976
8:142727544:C:GN66K0.976
8:142727724:G:CW126C0.976
8:142727724:G:TW126C0.976
8:142735362:T:AW184R0.976
8:142735362:T:CW184R0.976
8:142727722:T:AW126R0.975
8:142727722:T:CW126R0.975
8:142727542:A:TN66Y0.967
8:142735364:G:CW184C0.967
8:142735364:G:TW184C0.967
8:142727547:C:AN67K0.963
8:142727547:C:GN67K0.963
8:142727776:T:CF144L0.960
8:142727778:C:AF144L0.960
8:142727778:C:GF144L0.960
8:142727560:C:AR72S0.959
8:142727519:A:TD58V0.958
8:142727726:A:TD127V0.958

dbSNP variants (sampled 300 via entrez): RS1000052565 (8:142735498 A>T), RS1000972215 (8:142726722 C>A,T), RS1001456886 (8:142734490 G>A), RS1001690054 (8:142728264 T>A), RS1001886653 (8:142734863 G>A,T), RS1002180336 (8:142734548 C>A,T), RS1002246538 (8:142727189 C>A,G,T), RS1002637905 (8:142734205 C>T), RS1002961370 (8:142729229 T>G), RS1003160011 (8:142733428 T>C), RS1003188701 (8:142735565 C>T), RS1003593859 (8:142735782 G>A), RS1003705318 (8:142728007 C>A,G,T), RS1004379049 (8:142732573 T>C), RS1004569023 (8:142734458 A>G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL6066289 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

ChEMBL bioactivities

4 potent at pChembl≥5 of 4 total, top 4 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).

pChemblTypeValueUnitMolecule
7.21Kd62.14nMCHEMBL5653589
7.21ED5062.14nMCHEMBL5653589
5.77Kd1696nMCHEMBL3752910
5.77ED501696nMCHEMBL3752910

PubChem BioAssay actives

2 with measured affinity, of 4 total; 2 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.

CompoundAssayTypeValueUnit
4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide2149581: Binding affinity to human THEM6 incubated for 45 mins by Kinobead based pull down assaykd0.0621uM
4-methyl-3-[(1-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide2149581: Binding affinity to human THEM6 incubated for 45 mins by Kinobead based pull down assaykd1.6959uM

CTD chemical–gene interactions

43 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases expression, increases expression3
Valproic Acidaffects cotreatment, increases expression, affects expression, increases methylation3
bisphenol Aaffects expression, increases expression2
Copperaffects binding, increases expression, decreases expression2
Estradiolaffects cotreatment, decreases expression, affects binding, increases reaction2
Tobacco Smoke Pollutionaffects expression, decreases expression2
Cyclosporinedecreases expression2
bisphenol Fincreases expression1
cobaltous chloridedecreases expression1
perfluorooctanoic aciddecreases expression1
ferrous chloridedecreases expression1
2,3-bis(3’-hydroxybenzyl)butyrolactoneaffects cotreatment, increases expression1
S-(1,2-dichlorovinyl)cysteineaffects response to substance, increases expression, affects cotreatment, decreases expression1
di-n-butylphosphoric acidaffects expression1
K 7174decreases expression1
bisphenol Bincreases expression1
abrinedecreases expression1
2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidinedecreases expression, increases response to substance1
jinfukangincreases expression, affects cotreatment1
NSC 689534affects binding, decreases expression1
bisphenol AFincreases expression1
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acidincreases expression1
Bortezomibdecreases expression1
Benzo(a)pyreneaffects methylation1
Cadmiumincreases expression1
Cisplatinaffects cotreatment, increases expression1
Coumestrolincreases expression, affects cotreatment1
Demecolcinedecreases expression1
Disulfiramaffects binding, increases expression1
Formaldehydedecreases expression1

ChEMBL screening assays

1 unique, capped per target: 1 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL5652623BindingBinding affinity to human THEM6 incubated for 45 mins by Kinobead based pull down assayNVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.